Transmission dynamics of pertussis in China (2015–2024): A SEIARV compartmental model with waning immunity, annual parameter fitting, and stochastic forecasting for 2025–2027

Reported pertussis cases in China surged from 6,658 in 2015 to 476,690 in 2024 (a 71.6-fold increase), with a sharp decline during COVID-19 (2020) and an explosive resurgence in 2023–2024 despite sustained DTaP3 coverage above 95%; the transmission dynamics behind this resurgence remain incompletely quantified. In this national surveillance-based modeling study, we fitted a seasonally forced SEIARV compartmental model with waning immunity to all reported monthly pertussis cases of all ages in China (January 2015 to December 2024), reconstructed the time-varying effective reproduction number Re, and forecast 2025–2027 incidence under four transmission scenarios using 500-member stochastic ensembles. Re ranged from 0.88 (2020) to 1.37 (2023), with pre-pandemic values of 0.98–1.07 and annual fitting errors below 5% (in-sample RMSE 2.6%). A counterfactual analysis estimates that COVID-19 non-pharmaceutical interventions increased the effective susceptible population by approximately 14% by early 2023, an upper-bound estimate that cannot be fully separated from pandemic-era vaccine hesitancy. The fitted baseline transmission rate β0 rose from 8.96 month−1 (2020) to a decade-high 13.82 month−1 (2023; +29% vs. the pre-COVID-19 mean), and waning acellular-vaccine protection further amplified transmission (sensitivity index of Re to the waning rate: +0.79); their separate contributions cannot be formally decomposed in a homogeneous national model. Forecasts indicate that strengthened control could reduce annual cases to near zero by 2027 (median 0; 95% prediction interval 0–155), whereas continued waning or a return to historical-maximum transmission would sustain millions of cases (medians 9.3 and 10.8 million; outbreak probabilities 97–100%).

Authors

Institutions

Publication Details

Journal
Human Vaccines & Immunotherapeutics
Published
2026-11-19
DOI
https://doi.org/10.1080/21645515.2026.2760035
Primary Topic
Bacterial Infections and Vaccines
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Transmission dynamics of pertussis in China (2015–2024): A SEIARV compartmental model with waning immunity, annual parameter fitting, and stochastic forecasting for 2025–2027

Nan Zhou, Jin Zhao
Human Vaccines & Immunotherapeutics
Bacterial Infections and Vaccines
article

Transmission dynamics of pertussis in China (2015–2024): A SEIARV compartmental model with waning immunity, annual parameter fitting, and stochastic forecasting for 2025–2027

Nan Zhou, Jin Zhao
article en

Abstract

Reported pertussis cases in China surged from 6,658 in 2015 to 476,690 in 2024 (a 71.6-fold increase), with a sharp decline during COVID-19 (2020) and an explosive resurgence in 2023–2024 despite sustained DTaP3 coverage above 95%; the transmission dynamics behind this resurgence remain incompletely quantified. In this national surveillance-based modeling study, we fitted a seasonally forced SEIARV compartmental model with waning immunity to all reported monthly pertussis cases of all ages in China (January 2015 to December 2024), reconstructed the time-varying effective reproduction number Re, and forecast 2025–2027 incidence under four transmission scenarios using 500-member stochastic ensembles. Re ranged from 0.88 (2020) to 1.37 (2023), with pre-pandemic values of 0.98–1.07 and annual fitting errors below 5% (in-sample RMSE 2.6%). A counterfactual analysis estimates that COVID-19 non-pharmaceutical interventions increased the effective susceptible population by approximately 14% by early 2023, an upper-bound estimate that cannot be fully separated from pandemic-era vaccine hesitancy. The fitted baseline transmission rate β0 rose from 8.96 month−1 (2020) to a decade-high 13.82 month−1 (2023; +29% vs. the pre-COVID-19 mean), and waning acellular-vaccine protection further amplified transmission (sensitivity index of Re to the waning rate: +0.79); their separate contributions cannot be formally decomposed in a homogeneous national model. Forecasts indicate that strengthened control could reduce annual cases to near zero by 2027 (median 0; 95% prediction interval 0–155), whereas continued waning or a return to historical-maximum transmission would sustain millions of cases (medians 9.3 and 10.8 million; outbreak probabilities 97–100%).

Human Vaccines & ImmunotherapeuticsVol. 22(1)
Hunan University of Medicine (CN)
Bacterial Infections and Vaccines
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon